Insights On Trial Design

  1. Oncology Clinical Trials Key Considerations: Planning For Success 10/18/2024

    Chief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.

  2. Insights Into The Clinical Trials Landscape Of CL 4/8/2024

    Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  3. Overcoming Complex Patient Recruitment Challenges With Data 4/15/2025

    Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.

  4. Unlocking The Potential of RWD In Clinical Trial Recruitment 4/25/2025

    Insights derived from real-world data can be used not only to identify potential patients for participation in clinical research, but also to inform the overall patient engagement and retention strategy of a clinical trial.

  5. Linking Neurology And Ophthalmology For Clinical Trials 1/22/2025

    Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.

  6. The Future Of Patient Participation In Clinical Research 2/18/2025

    To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

  7. RTSM And IRT Solutions For Clinical Trials 12/10/2025

    Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

  8. Redefining Accessibility For Pediatric Patients 9/24/2025

    Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.

  9. Overview Of Diffuse Large B-cell Lymphoma: Global Clinical Trial Landscape 11/15/2024

    Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.

  10. Your Benefits To Working With A Clinical Research Marketing Agency 4/28/2025

    Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.